Total Payments
$4,113
2024 Payments
$763.86
Companies
11
Transactions
44
Medicare Patients
3,870
Medicare Billing
$605,408
Payment Breakdown by Category
Food & Beverage$4,113 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,113 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $1,238 | 14 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $696.02 | 6 | $0 (2024) |
| Alkermes, Inc. | $500.01 | 5 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $398.71 | 6 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $374.11 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $360.58 | 4 | $0 (2023) |
| Abbott Laboratories | $150.00 | 1 | $0 (2024) |
| Allergan Inc. | $125.00 | 1 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $124.75 | 1 | $0 (2024) |
| Amgen Inc. | $124.73 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $763.86 | 6 | Teva Pharmaceuticals USA, Inc. ($213.60) |
| 2023 | $19.78 | 1 | Otsuka America Pharmaceutical, Inc. ($19.78) |
| 2022 | $349.65 | 3 | Neurocrine Biosciences, Inc. ($229.65) |
| 2020 | $122.70 | 2 | ACADIA Pharmaceuticals Inc ($122.70) |
| 2019 | $445.65 | 5 | Neurocrine Biosciences, Inc. ($190.86) |
| 2018 | $850.07 | 7 | ACADIA Pharmaceuticals Inc ($350.36) |
| 2017 | $1,561 | 20 | ACADIA Pharmaceuticals Inc ($765.25) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $124.75 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $150.78 | General |
| Category: Neuropsychiatry | ||||||
| 06/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Diabetes Care | ||||||
| 06/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: Cardiology | ||||||
| 02/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $88.60 | General |
| Category: Neurology | ||||||
| 08/23/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), NUEDEXTA | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: PSYCHIATRY | ||||||
| 12/01/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: CNS | ||||||
| 09/20/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $104.65 | General |
| Category: Neuropsychiatry | ||||||
| 03/10/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neuropsychiatry | ||||||
| 03/11/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $100.96 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/19/2020 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/06/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $103.87 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $115.74 | General |
| Category: CNS | ||||||
| 04/30/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: Central Nervous System | ||||||
| 03/02/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: CNS | ||||||
| 02/28/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $86.99 | General |
| Category: NEUROLOGY | ||||||
| 10/05/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 09/27/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $113.57 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/22/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $118.39 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/08/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: CNS | ||||||
| 06/07/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 03/29/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $118.40 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/02/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $94.97 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 1,109 | 1,896 | $468,014 | $180,017 |
| 2022 | 3 | 928 | 1,502 | $376,941 | $143,627 |
| 2021 | 7 | 964 | 1,833 | $418,764 | $161,799 |
| 2020 | 6 | 869 | 1,599 | $303,216 | $119,965 |
Total Patients
3,870
Total Services
6,830
Medicare Billing
$605,408
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 571 | 614 | $267,036 | $91,389 | 34.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 494 | 1,188 | $178,484 | $79,553 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 64 | $14,807 | $5,197 | 35.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 16 | 17 | $5,412 | $2,619 | 48.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 13 | 13 | $2,275 | $1,259 | 55.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 480 | 532 | $230,841 | $82,919 | 35.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 424 | 946 | $141,900 | $58,693 | 41.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 24 | 24 | $4,200 | $2,015 | 48.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 420 | 445 | $193,130 | $69,725 | 36.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 379 | 1,079 | $161,850 | $67,126 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 107 | $19,225 | $8,438 | 43.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 38 | 98 | $14,700 | $5,844 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 38 | $8,550 | $4,278 | 50.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $10,625 | $2,901 | 27.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 23 | 27 | $4,725 | $2,249 | 47.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 14 | 14 | $5,959 | $1,238 | 20.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 389 | 916 | $122,850 | $54,501 | 44.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 268 | 288 | $100,997 | $34,669 | 34.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 61 | 145 | $24,175 | $9,679 | 40.0% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 56 | 115 | $16,350 | $7,131 | 43.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 71 | $15,975 | $6,755 | 42.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 44 | 45 | $19,269 | $5,776 | 30.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 19 | 19 | $3,600 | $1,454 | 40.4% |
About Dr. Ramsing Pardeshi, MD
Dr. Ramsing Pardeshi, MD is a Psychiatry healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205895760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramsing Pardeshi, MD has received a total of $4,113 in payments from pharmaceutical and medical device companies, with $763.86 received in 2024. These payments were reported across 44 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($4,113).
As a Medicare-enrolled provider, Pardeshi has provided services to 3,870 Medicare beneficiaries, totaling 6,830 services with total Medicare billing of $605,408. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Brooklyn, NY
- Active Since 03/22/2006
- Last Updated 10/10/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205895760
Products in Payments
- NUPLAZID (Drug) $1,238
- INGREZZA (Drug) $696.02
- LATUDA (Drug) $398.71
- REXULTI (Drug) $360.58
- Aristada 441 mg (Drug) $249.98
- UZEDY (Drug) $213.60
- FREESTYLE LIBRE 3 (Device) $150.00
- ARISTADA (Drug) $130.03
- VRAYLAR (Drug) $125.00
- AUSTEDO (Drug) $124.76
- Kerendia (Drug) $124.75
- Repatha (Biological) $124.73
- LYBALVI (Drug) $120.00
- SD809-TD (Drug) $35.75
- NUEDEXTA (Drug) $20.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brooklyn
Dr. Mark Owens, Do, DO
Psychiatry — Payments: $502,442
Psychiatry $502,442
Dr. Nancy Abdel-Wahab, M.d, M.D
Psychiatry — Payments: $194,999
Psychiatry $194,999
Louis Belzie, Md, Phd, MD, PHD
Psychiatry — Payments: $178,082
Psychiatry $178,082
Alexander Pinkusovich, Md, MD
Psychiatry — Payments: $111,246
Psychiatry $111,246
Dr. Mark Gurtovy, M.d, M.D
Psychiatry — Payments: $31,729
Psychiatry $31,729
Thresiamma Nidhiry, Md, MD
Psychiatry — Payments: $27,833
Psychiatry $27,833